Filter
1241
Filtered Results: 1241
Text search:
Eastern
and
Southern
Africa
Featured
Recommendations
82
New Publications
316
Language
Document type
No document type
694
Studies & Reports
336
Guidelines
83
Strategic & Response Plan
49
Manuals
36
Fact sheets
12
Situation Updates
10
Training Material
9
Infographics
9
Resource Platforms
3
Countries / Regions
Global
88
Africa
65
Kenya
61
Zambia
47
Sierra Leone
42
Ethiopia
42
South Africa
39
Uganda
32
Malawi
31
East and Southern Africa
30
Tanzania
27
Rwanda
25
Zimbabwe
23
Congo, Democratic Republic of
21
Liberia
20
Nigeria
20
South Sudan
20
Western and Central Europe
18
Syria
17
Ghana
16
Mozambique
16
Namibia
14
Yemen
14
Lesotho
13
West and Central Africa
13
Somalia
12
Middle East and North Africa
12
Eastern Europe and Central Asia
12
Myanmar / Burma
11
South–East Asia Region
11
India
10
Madagascar
9
Latin America and the Carribbean
9
Eastern Europe
9
Senegal
8
Afghanistan
8
Ukraine
8
Guinea
7
Nepal
7
Botswana
7
Sudan
6
Asia
6
Russia
6
Burkina Faso
5
Cameroon
5
Pakistan
5
Central African Republic
5
Haiti
4
Papua New Guinea
4
Eswatini/ Swaziland
4
Côte d’Ivoire / Ivory Coast
3
Philippines
3
Iraq
3
Jordan
3
Indonesia
3
Bangladesh
3
Burundi
3
Libya
3
Mexico
3
Iran
3
Mali
2
Morocco
2
Turkey
2
Chad
2
Cambodia
2
China
2
Brazil
2
Colombia
2
Western Pacific Region
2
Venezuela
2
Palestine
2
Moldova
2
Vietnam
2
Tunisia
2
USA
1
Saudi Arabia
1
Niger
1
Togo
1
Germany
1
Lebanon
1
Benin
1
Vanuatu
1
Peru
1
North Macedonia
1
Serbia
1
Greece
1
Angola
1
Sri Lanka
1
Solomon Islands
1
Poland
1
North Korea
1
Italy
1
Albania
1
Djibouti
1
Armenia
1
Southern Africa
1
Laos
1
Tajikistan
1
Qatar
1
Romania
1
Georgia
1
Gabon
1
France
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
449
Clinical Guidelines
74
Public Health
65
Women & Child Health
59
Key Resources
47
Capacity Building
10
Pharmacy & Technologies
5
Toolboxes
HIV
212
Planetary Health
93
COVID-19
78
Mental Health
67
TB
44
NTDs
39
Conflict
38
Global Health Education
38
Disability
36
Refugee
31
Natural Hazards
30
Rapid Response
28
AMR
23
Ebola
22
Health Financing Toolbox
15
Pharmacy
13
NCDs
13
Caregiver
12
Polio
9
Cholera
6
Zika
5
Social Ethics
5
South Sudan
2
Specific Hazards
2
Typhoon
1
an operational guide to support all those responsible for planning and implementing the rollout of COVID-19 vaccine to refugees and migrants at national a... local levels, 14 March 2022
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings ... is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT control during the past decade has prompted increasing global dialogue on its elimination and eradication. The disease is targeted by the World Health Organization (WHO) for elimination as a public health problem by 2020 and to terminate its transmission globally by 2030, along-side other Neglected Tropical Diseases (NTD). Several methods have been used to control tsetse flies and the disease transmitted by them. Old and new tools to control the disease are available with constraints.
Currently, there are no vaccines available. Efforts towards intervention to control the disease over the past decade have seen considerable progress and remarkable success with incidence dropping progressively, reversing the upward trend of reported cases. This gives credence in a real progress in its elimination. This study reviews various control measures, progress and a highlight of control issues, vector and parasite barriers that may have been hindering progress towards its elimination.
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution ... control activities are presented. Strong evidence indicates that the elimination of sleeping sickness ‘as a public health problem’ by 2020 is well within reach. In particular, fewer than one thousand new cases were reported in 2018, and the area where the risk of infection is estimated as moderate, high or very high has shrunk to less than 200,000 km2. More than half of this area is in the Democratic Republic of the Congo. The interruption of transmission of the gambiense form, targeted by the World Health Organization (WHO) for 2030, will require renewed efforts to tackle a range of expected and unexpected challenges. The rhodesiense form of the disease represents a small part of the overall HAT burden. For this form, the problem of under detection is on the rise and, because of an important animal reservoir, the elimination of disease transmission is not envisioned at this stage.
Oxford Policy Management (OPM) - APW with UNAIDS (thru TSF)
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...
Only 8,730 asylum applications were registered in the EU+ in April, the lowest since at least 2008, and a massive 87% decrease from pre-COVID-19 levels in January and February.
The European Asylum ...
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy ... responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug Report package.
Available in different languages: http://www.emcdda.europa.eu/publications/edr/trends-developments/2019_en
The Global Early Warning – Early Action (EWEA) report on food security and agriculture is developed by the Food and Agriculture Organization of the United Nations (FAO). The report is part of FAO...
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs program...
Based on an increasing body of evidence pointing at the positive impact that social assistance has had in Malawi, the region and beyond, government is encouraged to continue investing in and support...
As our world changes, so too does the burden of disease. Globalisation, evolving trade and consumption patterns, and increased access to life-saving medical care are just some of the factors that ha...
Mapping Children on the Move
recommended
In reviewing State Parties report on the implementation of the Charter, the Committee has identified children on the move as an emerging child protection issue in African, and therefore commissioned...
State of Health in the EU Cycle.
With the coronavirus (COVID-19) once again spreading rapidly, and the re-introduction of containment measures to flatten the curve of the epidemic, it is crucial for policymakers to plan effective strategies to re-o...
With focus on creating linkages between social cash transfer programmes and HIV services
Accessed: 21.08.2019
Supplement October 2010
HIV/AIDS, security and conflict: making the connections
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria ... methods for deciding the treatment among the new set of therapeutic options and the particular conditions that apply to treatment with fexinidazole, as outlined below. Because HAT is a serious, life-threatening disease and because the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as on completing the full 10-day
treatment schedule, the recommendations regarding fexinidazole administration are considered key elements that must be carefully followed. When the conditions listed in these guidelines are not met for any individual patient, the alternative available treatments should be prescribed.
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO N...
